David O. Sussman, DO
Accepting New Patients
A graduate of the University of New England College of Osteopathic Medicine, Dr. David Sussman is a member of many professional societies, including the American College of Osteopathic Surgeons. He completed a Fellowship in Infertility at Albert Einstein College of Medicine, and a Fellowship in Female Urology at Kaiser Permanente. Dr. Sussman is board certified by the American Osteopathic Board of Surgery, and has been in practice for more than 25 years.
Review David O. Sussman on Healthgrades: 
Locations
2 Executive Campus
2370 Route 70, Second Floor, Suite 205
Cherry Hill, NJ 08002
570 Egg Harbor Road, Suite A-1
Sewell, NJ 08080
Medical School
University of New England, College of Osteopathic Medicine – Biddeford, ME
Internship & Residency
University of Medicine and Dentistry of New Jersey, School of Osteopathic Medicine – Stratford, NJ
Languages Spoken
EnglishYears of Experience
25+
Awards
Ages Served
18+
Specialities
- Erectile Dysfunction
- Neurogenic Voiding Dysfunction
- Overactive Bladder (OAB)
- Pelvic Prolapse
- Prosthetics
- Urinary Incontinence
- Voiding Dysfunction
Schedule an Appointment
For “New Patient” visits only.
-
ALL CONDITIONS TREATED
- Benign Prostatic Hyperplasia (BPH)
- Erectile Dysfunction
- Female Urology
- Interstim Therapy
- Male Hernia Surgery
- Neurogenic Bladder
- Neurogenic Voiding Dysfunction
- Overactive Bladder (OAB)
- Pelvic Prolapse
- Prosthetics
- Urinary Incontinence
- Voiding Dysfunction
-
MEMBERSHIPS
- American College of Osteopathic Surgeons
- American Fertility Society
- New Jersey Patient Care and Access Coalition
- American Association of Clinical Urologists
- American Urologic Association
- American Osteopathic Association (Delegate to NJAOPS)
- Camden County Society of Osteopathic Physicians and Surgeons
- New Jersey Association of Osteopathic Physicians and Surgeons
- Philadelphia Urology Society
- Urology Society of New Jersey
- International Continence Society
- Society for Urodynamics and Female Urology
-
AWARDS & HONORS
- Top Physician, South Jersey Magazine (2018)
- Reader’s Choice, South Jersey’s Best Physicians (2013)
- Reader’s Choice, South Jersey Magazine
-
RESEARCH & PUBLICATIONS
Publications
- Perforated Sigmoid Diverticulitis: Case Report and Literature Review-June 1987
- Renal Liposarcoma: Case Report and Literature Review-June 1988
- Squamous Cell Carcinoma in a Female Urethral Diverticulum-June 1990
- Stage C Prostate Carcinoma:Total Androgen Ablation Prior to Radical Retropubic Prostatectomy-Poster Presentation-ACOS Annual Meeting-October 1990
- Penile Prosthetic Infections Utilizing The Surgical Isolation Bubble System (SIBS) June 1991
- Current Operative Approaches to Benign Prostatic Hyperplasia-The Journal-NJAOPS December 1991
- Treatment Options for Benign Prostatic Hyperplasia-N.J. Journal-NJAOPS-December 1991
- The Urologist’s Role in the Evaluation of the Infertile Couple-The Journal-NJAOPS December 1991
- Editor-The Journal-NJAOPS-December 1991
- Treatmentof Calculus Disease in the 90’s-Co-Author-The Journal-NJAOPS December 1992
- In-Situ Vesical Wall Sling (Vesica) For the Treatment of Stress Urinary Incontinence The Journal-NJAOPS-May 1997
- Poster Presentation-ACET Trial-ACOS Convention, Orlando, Florida-2002
- Poster Presentation-PVS/Cystocele Repair-ACOS Convention, Orlando, Florida-2002
- Poster Presentation-PVS Repair-Repliform-ACOS Convention, Orlando, Florida-2002
- Poster Presentation-ACET Trial-European Association of Urology-Birmingham, England 2002
- Sussman D, Garely A. Treatment of Overactive Bladder with Once-daily Extended-release Tolterodine or Oxybutinin: The Antimuscarinic Clinical Effectiveness Trial (ACET) , Current Medical Research Opinion 2002:18(4); 177-1
- Sussman, D. Pharmacokinetics, Pharmacodynamics and Efficacy of Phosphodiesterase Type 5 Inhibitors. JAOA.Supplement 4.2004;104:S11-15
- Brown, GA, Sussman, DO. A Current Review of Medical Therapy for Benign Prostatic Hyperplasia. JAOA Supplement 2. 2004; 104: S11-16
- Poster Presentation-Dry mouth was more pronounced in patients with overactive bladder treated with extended-release oxybutinin compared to tolterodine. European Association of Urology – Istanbul, Turkey 2004
- Poster presentation-The tolerability of tolterodine is not diminished in older patients with overactive bladder: An analysis of 5 randomized, double-blind placebo controlled trials. 64th Annual Meeting of the Mid-Atlantic Section of the AUA. Washington, D.C. 2006
- Poster Presentation-Effects of Tolterodine extended release and/or tamsulosin on bladder Diary variables and patient-reported outcomes in men with lower urinary tract symptoms Including OAB European Association of Urology-Berlin, Germany 2007
- Sussman, David O., Kraus, Stephen R. Onset of Efficacy of Tolterodine Extended Release In patients with overactive bladder, Current Medical Research and Opinion 2007:23(4) 777-781
- Sussman, David O. Overactive Bladder:Treatment Options in Primary Care Medicine. J. Am Osteopathic Assoc 2007;107(9):379-385
- Rovner, ES, Kreder, K, Sussman, DO, Kaplan, SA, Carlsson, M et al. Effect of Tolterodine Extended Release with or without Tamsulosin on Measures of Urgency and Patient Reported Outcomes in Men with Lower Urinary Tract Symptoms. J.Urology 2008; 1034-1041
- Sussman, D., Patel, V., Del Popolo, G., Lam, W., Globe, D., Pomerville, P.,Treatment Satisfaction and Improvement in Health Related Quality of Life with Onabotulinumtoxin A in Patients with Urinary Incontinence Due to Neurogenic Detrussor Overactivity. Accepted for Publication Neurourology and Urodynamics 2013
- Poster Presentation-Nitti, V., Chapple, C., Sand, P., Sussman, D., et. al. OnabotulinumtoxinA in Patients with Overactive Bladder and Urinary Incontinence: Consistent Effect Over Repeated Treatments-Accepted AUA 2013 San Diego, CA
- Nitti V, Sievert K, Chapple C, Sussman D, et al. Clinically Meaningful Improvements in Urinary Incontinence and Quality of Life Over Multiple Treatment Cycles of OnabotulinumtoxinA in Patients with OAB syndrome and Urinary Incontinence: Interim Analysis of as Long Term Extension Study. ICS abstract. Barcelona, Spain 2013
- Sand P, Egerdie B, Sussman D, et al. Greater Improvement in health Related Quality of Life after OnabotulinumtoxinA Treatment are Associated with Greater Reduction in Urinary Incontinence in Patients with OAB syndrome: Results from Two Phase 3 Studies. ICS abstract. Barcelona, Spain 2013
- Sievert, K-D, Chapple CR, Sussman DO, Radomski, S et al. Consistent Improvement in Urinary Urgency Following repeat OnabotulinumtoxinA Treatments in Patients with Overactive Bladder Syndrome and Urinary Incontinence. Abstract accepted at EAU 2014 Stochholm, Sweden
- Everaert K, Gruenfelder J, Schulte-Backloh H, Guard S, Zheng Y, Sussman D. OnabotulinutoxinA Reduces Urinary Incontinence and Improves Quality of Life in Overactive Bladder Patients Regardless of Use of Clean Intermittent Catheterization or the Presence of Urinary Tract Infection. Abstract accepted at SUFU 2014 Miami, Fl
- Radomski S, Chapple CR, Sussman, DO, Sand PK, Guard S, Zhou J, Sievert K-D, Nitti . Repeat OnabotulinumtoxinA Treatment for Overactive Bladder and Urinary Incontinence: Interim Analysis of Long Term Efficacy and Safety Data with 2.4 years Follow-Up Abstract accepted CUA 2014 St. Johns,NL
-
HOSPITAL AFFILIATIONS
- Inspira (Elmer, Vineland, Woodbury)
- Jefferson Health New Jersey (Cherry Hill, Stratford, Washington Township)
- Virtua (Marlton, Voorhees)
-
ACCEPTED INSURANCE
Always check with your health insurance carrier before scheduling any type of service. You can learn the details of your individual health insurance plan, including the amount of your copay, deductible, and coinsurance by visiting your health insurance company’s website or by calling their customer service department.